If you suspect mold in your home or workplace, or you have unexplained symptoms that seem tied to a particular building, this test can tell you whether a specific family of mold toxins is showing up in your body. Chaetoglobosin A is a poisonous compound made by Chaetomium mold, a common culprit in water-damaged buildings. Finding it in your urine means you have been exposed to that mold recently enough for the toxin to still be circulating.
This is an exploratory marker without standardized clinical cutpoints. No medical guidelines currently define what a "safe" or "dangerous" urinary level looks like, and there are no large human outcome studies tying specific concentrations to specific diseases. What the test does offer is a concrete, objective signal of exposure, which can be the missing piece when you are trying to figure out whether a building is making you sick.
Chaetoglobosin A belongs to a class of fungal poisons called cytochalasan alkaloids. These are complex molecules that certain mold species produce as part of their natural chemistry. The primary producer is Chaetomium globosum, a mold that thrives on wet drywall, ceiling tiles, and other cellulose-rich materials in water-damaged buildings. When this mold grows indoors, it releases spores and fragments that carry chaetoglobosin A into the air you breathe or onto surfaces you touch.
Once these toxins enter your body through inhalation, skin contact, or ingestion, they are eventually processed and excreted in urine. A urine test for chaetoglobosin A is essentially asking: has Chaetomium mold toxin gotten into your system?
In laboratory cell experiments, chaetoglobosins (the broader family that includes chaetoglobosin A) show strong toxic effects on human cells. They can kill cancer cell lines at very low concentrations, which demonstrates their potency as cell-damaging agents. While this toxicity has drawn interest from researchers looking for new cancer drugs, the flip side is that these are not compounds you want circulating in your body from environmental exposure.
The honest limitation here is that nearly all of the toxicity data comes from laboratory cell experiments, not from studies tracking what happens to people exposed to chaetoglobosin A over months or years. No human outcome studies have linked specific urinary levels of this toxin to defined diseases. That does not mean exposure is harmless. It means the science has not yet caught up to measuring exactly how harmful it is at various doses in real people.
A positive result (detectable chaetoglobosin A in your urine) confirms that Chaetomium mold toxin has entered your body. This is useful for several reasons. It validates that an exposure is real, not imagined. It can help identify mold as a possible contributor to chronic unexplained symptoms like fatigue, headaches, or respiratory irritation in people who live or work in water-damaged buildings. And it gives you a baseline to compare against after remediation, so you can confirm that fixing the mold problem actually reduced your exposure.
What the test cannot do is diagnose a specific disease or tell you precisely how much harm the exposure has caused. There are no established thresholds separating "safe" from "unsafe" levels. A detectable result is a signal to investigate your environment and reduce exposure, not a diagnosis.
No standardized clinical reference ranges exist for urinary chaetoglobosin A. Labs that offer this test typically report results as either "detected" or "not detected," or provide a numeric value alongside the lowest concentration their equipment can reliably measure. Because there is no published consensus on what concentration is clinically meaningful, any numeric result should be interpreted as a relative indicator of exposure rather than a clinical diagnosis.
If your result comes back above the detection limit, it confirms recent exposure to Chaetomium mold. If it is below the detection limit, it means either you have not been exposed recently or the exposure was too low or too distant in time for the toxin to appear in your urine at measurable levels.
Because there are no consensus cutpoints for this toxin, tracking your own trend over time is the most useful way to interpret results. A single reading tells you whether exposure is happening right now. A series of readings tells you whether the problem is getting better or worse, and whether remediation efforts are actually working.
A practical approach: get a baseline test when you first suspect mold exposure, then retest 4 to 8 weeks after remediation or after removing yourself from the suspect environment. If levels drop to undetectable, that is strong evidence the source has been addressed. If levels persist, the exposure source may still be active or there may be a second source you have not identified.
For ongoing monitoring in a building you cannot leave (such as a workplace), testing every 3 to 6 months can help you detect seasonal spikes in mold growth, which tend to occur during humid months or after water intrusion events.
If chaetoglobosin A is detected in your urine, the first step is environmental investigation. Have your home or workplace professionally assessed for water damage and mold growth, with specific attention to Chaetomium species. A qualified mold inspector can take air and surface samples to identify whether Chaetomium is present and where it is growing.
At the same time, consider testing for the full panel of common mycotoxins (ochratoxin A, aflatoxins, trichothecenes, and others). Finding multiple mycotoxins suggests broad mold contamination rather than a single-species problem, which changes the scope of remediation needed. If you are experiencing symptoms like persistent fatigue, respiratory issues, cognitive difficulty, or skin irritation, bring your test results to a physician experienced in environmental medicine. They can help determine whether your symptoms are consistent with mold exposure and whether additional workup is warranted.
The most effective intervention is always source removal. Professional mold remediation of the contaminated space, combined with fixing the underlying moisture problem, is the standard approach. Retesting your urine after remediation confirms whether the intervention worked.
Evidence-backed interventions that affect your Chaetoglobosin A level
Chaetoglobosin A is best interpreted alongside these tests.